$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Use of GLP-1 or analogs in treatment of myocardial infarction 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-038/26
  • A61K-038/17
  • C07K-014/605
출원번호 US-0915918 (1997-08-21)
발명자 / 주소
  • Efendic Suad,SEX
출원인 / 주소
  • Eli Lilly and Company
대리인 / 주소
    Stewart
인용정보 피인용 횟수 : 98  인용 특허 : 6

초록

This invention provides a method of reducing mortality and morbidity after myocardial infarction. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.

대표청구항

[ I claim:] [1.]1. A method of reducing mortality and morbidity after myocardial infraction, comprising administering to a patient in need thereof, a compound selected from the group consisting of GLP-1, GLP-1 analogs, GLP-1 derivatives and pharmaceutically-acceptable salts thereof, at a dose effect

이 특허에 인용된 특허 (6)

  1. Tarnowski S. Joseph (Sunnyvale) Hilliker Sandra (Riverside) Willett W. Scott (San Francisco CA), Expression of recombinant polypeptides with improved purification.
  2. Habener Joel (Newton Highlands MA), Insulinotropic hormone.
  3. Habener Joel F. (Newton MA), Insulinotropic hormone.
  4. Habener Joel F. (Newton Highlands MA), Insulinotropic hormone GLP-1 (7-36) and uses thereof.
  5. Efendic Suad,SEX, Use of GLP-1 or analogs to abolish catabolic changes after surgery.
  6. Efendic Suad (Lindingo SEX) Gutniak Mark (Hasselby SEX) Kirk Ole (Virum DKX), Use of a peptide.

이 특허를 인용한 특허 (98)

  1. Rosen, Craig A.; Haseltine, William A.; Ballance, David J.; Turner, Andrew J.; Ruben, Steven M., Albumin fusion proteins.
  2. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  3. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  4. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  5. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  6. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  7. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  8. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  9. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  10. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M.; Moore, Paul A.; Bock, Jason B.; LaFleur, David, Albumin fusion proteins.
  11. Rosen,Craig A.; Haseltine,William A.; Ruben,Steven M., Albumin fusion proteins.
  12. Rosen,Craig A.; Haseltine,William A.; Ballance,David J.; Turner,Andrew J.; Ruben,Steven M., Albumin fusion proteins comprising GLP-1 polypeptides.
  13. Zhang, Cheng; Jing, Shuqian; Zhang, Hua; Wang, Xiaofeng; Yao, Chenjiang, Antibody specifically binding to GLP-1 R and fusion protein thereof with GLP-1.
  14. Zhang, Cheng; Jing, Shuqian; Zhang, Hua; Wang, Xiaofeng; Yao, Chenjiang, Antibody specifically binding to GLP-1R and fusion protein thereof with GLP-1.
  15. Adamo, Benoit; Polidoro, John M.; Overfield, Dennis; Sahi, Carl R.; Laurenzi, Brendan; Smutney, Chad C.; Kinsey, P. Spencer, Apparatus and method for simulating inhalation efforts.
  16. Adamo, Benoit; McLean, Scott; Smutney, Chad C.; Polidoro, John M.; Sahi, Carl R., Apparatus, system and method for measuring resistance of an inhaler.
  17. Stevenson, John J.; Moye-Sherman, Destardi, Catalysis of diketopiperazine synthesis.
  18. Stevenson, John J.; Moye-Sherman, Destardi, Catalysis of diketopiperazine synthesis.
  19. Hathaway, David R.; Coolidge, Thomas R., Compositions and methods for treating peripheral vascular disease.
  20. Richardson, Peter; Baughman, Robert A.; Leone-Bay, Andrea; Costello, Donald, Delivery of active agents.
  21. Grant, Marshall L.; Stowell, Grayson W.; Menkin, Paul, Diketopiperazine microparticles with defined specific surface areas.
  22. Leone-Bay, Andrea; Moye-Sherman, Destardi; Wilson, Bryan R., Diketopiperazine salts for drug delivery and related methods.
  23. Leone-Bay, Andrea; Moye-Sherman, Destardi; Wilson, Bryan R., Diketopiperazine salts for drug delivery and related methods.
  24. Smutney, Chad C.; Adamo, Benoit; Laurenzi, Brendan F.; Kinsey, P. Spencer, Dry powder drug delivery system and methods.
  25. Smutney, Chad C.; Adamo, Benoit; Polidoro, John M.; Kinsey, P. Spencer; Overfield, Dennis; Sahi, Carl; Billings, Christine; Marino, Mark T., Dry powder drug delivery system and methods.
  26. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Bryant, Anthony, Dry powder inhaler and system for drug delivery.
  27. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Bryant, Anthony; He, Tom; Mann, Alfred, Dry powder inhaler and system for drug delivery.
  28. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Kraft, Kelly S.; Somerville, Karla, Dry powder inhaler and system for drug delivery.
  29. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Kraft, Kelly S.; Somerville, Karla, Dry powder inhaler and system for drug delivery.
  30. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfiled, Dennis; Bryant, Anthony, Dry powder inhaler and system for drug delivery.
  31. DiPerna, Paul M, Flow regulating stopcocks and related methods.
  32. Fleer,Reinhard; Fournier,Alain; Guitton,Jean Dominique; Jung,G��rard; Yeh,Patrice, Fusion polypeptides of human serum albumin and a therapeutically active polypeptide.
  33. Shelton, Anne Pernille Tofteng; Nørregaard, Pia; Deryabina, Maria Alexandrovna; Larsen, Bjarne Due; Fog, Jacob Ulrik, GIP agonist compounds and methods.
  34. Shelton, Anne Pernille Tofteng; Nørregaard, Pia; Fog, Jacob Ulrik; Knudsen, Carsten Boye, GIP-GLP-1 dual agonist compounds and methods.
  35. Tolborg, Jakob Lind; Neerup, Trine Skovlund Ryge; Fosgerau, Keld; Østerlund, Torben; Almholt, Dorthe Lennert Christensen; Larsen, Lone Frost, GLP-1 receptor agonist peptide gastrin conjugates.
  36. Tolborg, Jakob Lind; Fosgerau, Keld; Nørregaard, Pia; Just, Rasmus; Riber, Ditte; Hamprecht, Dieter Wolfgang; Augustin, Robert; Thomas, Leo; Rist, Wolfgang, Glucagon analogues.
  37. Tolborg, Jakob Lind; Fosgerau, Keld; Nørregaard, Pia; Just, Rasmus; Riber, Ditte; Hamprecht, Dieter Wolfgang; Augustin, Robert; Thomas, Leo; Rist, Wolfgang, Glucagon analogues.
  38. Just, Rasmus; Riber, Ditte; Shelton, Anne Pernille Tofteng; Østerlund, Torben; Hansen, Kate; Jessen, Lene, Glucagon-GLP-1-GIP triple agonist compounds.
  39. Fabio, Karine; Guarneri, Joseph J.; Curley, Kieran; Grant, Marshall L.; Leone-Bay, Andrea, Heat-stable dry powder pharmaceutical compositions and methods.
  40. Grant, Marshall; Menkin, Paul; Stowell, Grayson W., High capacity diketopiperazine microparticles and methods.
  41. Grant, Marshall; Menkin, Paul; Stowell, Grayson W., High capacity diketopiperazine microparticles and methods.
  42. Fleer,Reinhard; Fournier,Alain; Guitton,Jean Dominique; Jung,G챕rard; Yeh,Patrice, Hormone and albumin fusion protein.
  43. Hokenson, Mark; Oberg, Keith A., Increasing drug affinity for crystalline microparticle surfaces.
  44. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  45. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  46. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  47. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  48. Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  49. Smutney, Chad C.; Leone-Bay, Andrea; Galarza, Jose M.; Munoz, Hector; Martin, George R.; Grant, Marshall L., Inhalable vaccine compositions and methods.
  50. Poole, Trent; Steiner, Solomon S., Inhalation apparatus.
  51. Habener, Joel F., Insulinotropic hormone and uses thereof.
  52. Habener,Joel F.; Mojsov,Svetlana, Insulinotropic hormone derivatives and uses thereof.
  53. Overfield, Dennis; Sahi, Carl R.; Adamo, Benoit; Kinsey, P. Spencer; McLean, Scott; Polidoro, John M.; Smutney, Chad C., Interactive apparatus and method for real-time profiling of inhalation efforts.
  54. Coolidge, Thomas R.; Ehlers, Mario R. W., Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain.
  55. Leone-Bay, Andrea; Stowell, Grayson W.; Guarneri, Joseph J.; Carlson, Dawn M.; Grant, Marshall; Smutney, Chad C., Method and composition for treating migraines.
  56. Wilson, Bryan R.; Grant, Marshall, Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent.
  57. Wilson, Bryan R.; Grant, Marshall, Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent.
  58. Bousquet Gagnon,Nathalie; Quraishi,Omar; Bridon,Dominique P., Method for purification of albumin conjugates.
  59. Hokenson, Mark; Oberg, Keith A., Method of drug formulation.
  60. Oberg, Keith A.; Sulner, Joseph; Grant, Marshall L., Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents.
  61. Oberg, Keith A.; Sulner, Joseph; Grant, Marshall L., Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents.
  62. Coolidge, Thomas R.; Ehlers, Mario, Method of performing angioplasty with a GLP-1 molecule.
  63. Richardson, Peter; Baughman, Robert A.; Costello, Donald, Method of preventing adverse effects by GLP-1.
  64. Richardson, Peter; Baughman, Robert A.; Potocka, Elizabeth; Boss, Anders Hasager; Petrucci, Richard, Method of treating diabetes type 2 by administering ultrarapid acting insulin.
  65. Bridon, Dominique P.; Castaigne, Jean-Paul; Thibaudeau, Karen, Method of treatment of diabetes and/or obesity with reduced nausea side effect.
  66. Steiner, Solomon S.; Woods, Rodney J.; Sulner, Joseph W., Methods and compositions for delivering peptides.
  67. Leone-Bay, Andrea; Houghten, Richard A.; Guarneri, Joseph J.; Stowell, Grayson W., Methods and compositions for treating pain.
  68. Leone-Bay, Andrea; Houghten, Richard A.; Guarneri, Joseph J.; Stowell, Grayson W., Methods and compositions for treating pain.
  69. Leone-Bay, Andrea; Houghten, Richard A.; Guarneri, Joseph J.; Stowell, Grayson W., Methods and compositions for treating pain.
  70. Van Den Berghe,Greta, Methods and preparations for curing clinically ill patients.
  71. Bush, Mark A.; Matthews, Jessica E.; Walker, Susan E., Methods for administering long-lasting hypoglycemic agents.
  72. Drucker, Daniel J.; Baggio, Laurie Lynn, Methods for treating disorders of the gastrointestinal tract using a GLP-1 agonist.
  73. Jucker, Beat M.; Lepore, John J.; Olson, Eric J., Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection.
  74. Neerup, Trine Skovlund Ryge; Østerlund, Torben; Tolborg, Jakob Lind; Fosgerau, Keld; Martensson, Ulrika; Brorson, Marianne; Rolsted, Kamilla, Peptide conjugates of GLP-1 receptor agonists and gastrin and their use.
  75. Neerup, Trine Skovlund Ryge; Østerlund, Torben; Tolborg, Jakob Lind; Fosgerau, Keld; Mårtensson, Ulrika; Brorson, Marianne; Rolsted, Kamilla, Peptide conjugates of GLP-1 receptor agonists and gastrin and their use.
  76. Bush, Mark A.; Stewart, Murray W.; Yang, Yonghong, Pharmaceutical compositions.
  77. Boss, Anders Hasager; Steiner, Solomon S.; Woods, Rodney J.; Sulner, Joseph W., Potentiation of glucose elimination.
  78. Boss, Anders Hasager; Steiner, Solomon S.; Woods, Rodney J.; Sulner, Joseph W., Potentiation of glucose elimination.
  79. Lau, Jesper Færgeman; Andersen, Asser Sloth; Bloch, Paw; Lau, Jesper; Garibay, Patrick William; Kruse, Thomas; Nørby, Inga Sig Nielsen; Jessen, Claus Ulrich; Christensen, Caspar; Norrild, Jens Christian, Semi-recombinant preparation of GLP-1 analogues.
  80. DiPerna, Paul M., Slideable flow metering devices and related methods.
  81. Brown, David, Solute concentration measurement device and related methods.
  82. Ebbehøj, Kirsten; Jepsen, Trine; Knudsen, Carsten Boye; Larsen, Bjarne Due; Knott, David, Stabilized Exendin-4 compounds.
  83. Bachovchin, William W.; Lai, Hung-Sen; Sanford, David George, Stable analogs of peptide and polypeptide therapeutics.
  84. Bachovchin, William W.; Lai, Hung-sen; Sanford, David George, Stable analogs of peptide and polypeptide therapeutics.
  85. Bachovchin,William W.; Lai,Hung sen; Sanford,David George, Stable analogs of peptide and polypeptide therapeutics.
  86. Kraft, Kelly Sullivan, Substituted diketopiperazine analogs for use as drug delivery agents.
  87. Kraft, Kelly Sullivan, Substituted diketopiperazine analogs for use as drug delivery agents.
  88. Kraft, Kelly Sullivan, Substituted diketopiperazine analogs for use as drug delivery agents.
  89. Rosinko, Michael J.; Kruse, Geoffrey A.; Harris, Paul, System and method for detecting occlusions in an infusion pump.
  90. Metzmaker, Thomas; Saint, Sean; Michaud, Michael; Rosinko, Michael J.; Swanson, Vance, Systems including vial adapter for fluid transfer.
  91. Coolidge, Thomas R.; Ehlers, Mario, Treatment of acute coronary syndrome with GLP-1.
  92. Coolidge,Thomas R.; Ehlers,Mario, Treatment of acute coronary syndrome with GLP-1.
  93. Coolidge, Thomas R.; Ehlers, Mario, Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide.
  94. Coolidge, Thomas R.; Ehlers, Mario, Treatment of hibernating myocardium with an exendin peptide.
  95. DiPerna, Paul M., Two chamber pumps and related methods.
  96. Knudsen, Lotte Bjerre; Selmer, Johan; Hansen, Kristian Tage, Use of GLP-1 compound for treatment of critically ill patients.
  97. Anderson, Christen; Liu, Que, Use of exendin and analogs thereof to delay or prevent cardiac remodeling.
  98. Richardson, Peter; Baughman, Robert A.; Potocka, Elizabeth; Boss, Anders Hasager; Petrucci, Richard, Use of ultrarapid acting insulin.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로